NEW YORK (GenomeWeb News) – Myriad Genetics' investment into RainDance Technologies totals $5.0 million, the Salt Lake City-based company said in its Form 10-Q filed with the US Securities and Exchange Commission this week.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.
Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.
Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.
By analyzing tweets, Canadian researchers examine the public's view of gene patenting.